DEA Archived Press Releases

Press Releases before January 20, 2025
329 Results - Showing 311 to 320
PRESS RELEASE

Manhattan U.S. Attorney announces extradition of OFAC- sanctioned Afghan man for Narco-Terrorism offenses

NEW YORK - Christopher Tersigni, Special Agent in Charge of the United States Drug Enforcement Administration Special Operations Division and Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced today the extradition of Haji Abdul Satar Abdul Manaf, aka “Haji Abdul Sattar Barakzai,” for...
PRESS RELEASE

Former owner of Chicago medical clinic guilty of selling opioid prescriptions to patients who lacked medical need for the drugs

CHICAGO - The former owner of a Chicago medical clinic admitted in federal court today that he sold opioid prescriptions to patients whom he knew lacked a legitimate medical need for the drugs. MOHAMMED SHARIFF, who owned Midtown Medical Center in Chicago’s Uptown neighborhood, conspired with a physician to sell...
PRESS RELEASE

DEA releases 2018 National Drug Threat Assessment

WASHINGTON – DEA Acting Administrator Uttam Dhillon today announced results of the 2018 National Drug Threat Assessment, which outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. “This report underscores the scope and magnitude of the ongoing opioid crisis...
PRESS RELEASE

Lasalle County Doctor Sentenced for Dispensing Prescription Drugs to Addicts for Sex

CHICAGO - A LaSalle County physician was sentenced today to 12 years in federal prison for illegally dispensing prescription medications, including opioids, in exchange for cash or sex. Constantino Perales, M.D., illegally prescribed oxycodone and Xanax to a patient, Andrew Strandell, knowing that Strandell would sell the pills on the...
PRESS RELEASE

DEA acts against dangerous, deadly designer synthetic drug linked to 151 overdose deaths since 2015

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...
PRESS RELEASE

Record settlement reached in University of Michigan hospital drug diversion civil penalty case

DETROIT - The Drug Enforcement Administration and United States Attorney’s Office for the Eastern District of Michigan today announced that the University of Michigan Health System has agreed to pay the United States $4.3 million as part of a settlement resolving allegations that UMHS violated certain provisions of the Controlled...
PRESS RELEASE

DEA investigators seeking answers in small Tennessee town

CELINA, Tenn. -- DEA investigators this week conducted inspections at several pharmacy locations in the Clay County, Tennessee town of Celina, following an inquiry into irregular patterns of pill purchases from drug distribution companies. DEA is now investigating possible criminal activity involving the illicit diversion of controlled prescription pharmaceuticals at...
PRESS RELEASE

Justice Department, DEA propose significant opioid manufacturing reduction in 2019

WASHINGTON – The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction for controlled substances that may be manufactured in the U.S. next year. Consistent with President Trump’s “Safe Prescribing Plan” that seeks to “cut nationwide opioid prescription fills by one-third within three years,” the proposal decreases...
PRESS RELEASE

Upper East Side doctor convicted in Brooklyn Federal Court of causing overdose death of a patient

BROOKLYN, N.Y. - A federal jury in Brooklyn today, following two weeks of trial, convicted Dr. Martin Tesher of 10 counts of unlawful distribution of oxycodone without legitimate medical purpose to five patients, one of whom died as a result two days after his last visit with the defendant. When...
PRESS RELEASE

Tampa doctor pleads guilty to distributing opioids outside DEA registration

TAMPA, Fla. – Jeffrey John Abraham (52, formerly of Tampa) has pleaded guilty to distributing controlled substances not specified in his Drug Enforcement Administration (DEA) registration. He faces a maximum penalty of four years’ imprisonment and a fine of up to $250,000. His sentencing date has not yet been set...